Volume 9, Number 8—August 2003

Dispatch

NmcA Carbapenem-hydrolyzing Enzyme in Enterobacter cloacae in North America¹

Sudha Pottumarthy*, Ellen Smith Moland†, Stefan Juretschko*, Susan R. Swanzy*, Kenneth S. Thomson†, and Thomas R. Fritsche* 

Author affiliations: *University of Washington School of Medicine, Seattle, Washington, USA; †Creighton University Medical Center, Omaha, Nebraska, USA

Main Article

Figure 2

Figure 2. Effect of addition of clavulanic acid (10 μL of 1,000 μg/mL) to the zones of inhibition of the three carbapenem disks. Top row (left to right): imipenem, meropenem, and ertapenem disks without clavulanic acid. Bottom row (left to right): imipenem, meropenem, and ertapenem disks with clavulanic acid.

Main Article

¹This work was presented in part at the 13th Annual European Congress of Clinical Microbiology and Infectious Diseases, Glasgow, Scotland, 2003.

Top of Page

The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.